<--- Back to Details
First PageDocument Content
Chemistry / Pharmacology / Teratogens / Prodrugs / Sodium valproate / Topiramate / Carbamazepine / Phenytoin / Vigabatrin / Anticonvulsants / Mood stabilizers / Medicine
Date: 2014-05-13 00:33:47
Chemistry
Pharmacology
Teratogens
Prodrugs
Sodium valproate
Topiramate
Carbamazepine
Phenytoin
Vigabatrin
Anticonvulsants
Mood stabilizers
Medicine

Health Care Checklist People with an intellectual disability may not be able to communicate how they are feeling. The presence of any of the following may indicate side effects from medication or injury from seizure acti

Add to Reading List

Source URL: www.qcidd.com.au

Download Document from Source Website

File Size: 56,05 KB

Share Document on Facebook

Similar Documents

GABAA receptor positive allosteric modulators / Anticonvulsants / RTT / Barbiturates / Sodium channel blockers / Primidone / Phenobarbital / Epilepsy / Epileptic seizure / Valproate / Phenytoin

CURRENT MEDICATIONS: Topamax 300 mg. b.i.d. Phenobarbital 130 mg daily Sinemett.i.d. Carnitor 1650 mgs. q.i.d.

DocID: 1p3pL - View Document

sodium valproate 16-sodium valproate (CAS # valproic acid (CAS # Table 1a. Sub-lethal acute poisoning (single dose): Clinical observations (time related) Notes Ref Reference (linked to Case Case

sodium valproate 16-sodium valproate (CAS # valproic acid (CAS # Table 1a. Sub-lethal acute poisoning (single dose): Clinical observations (time related) Notes Ref Reference (linked to Case Case

DocID: 1eaLB - View Document

CMDh agrees to strengthen warnings on the use of valproate medicines in women and girls

CMDh agrees to strengthen warnings on the use of valproate medicines in women and girls

DocID: 1awP4 - View Document

Global Addiction Belgrade 2015 Chair: Dr Andrej Kastelic Global Addiction Belgrade 2015 Guidelines for the Submission of Oral Symposia, Oral Session and

Global Addiction Belgrade 2015 Chair: Dr Andrej Kastelic Global Addiction Belgrade 2015 Guidelines for the Submission of Oral Symposia, Oral Session and

DocID: 1awq8 - View Document

*** Drug Safety Alert *** May 6, 2013, the U.S. Food and Drug Administration (FDA) advised health care professionals and women that the anti-seizure medication valproate sodium and related products, valproic acid and div

*** Drug Safety Alert *** May 6, 2013, the U.S. Food and Drug Administration (FDA) advised health care professionals and women that the anti-seizure medication valproate sodium and related products, valproic acid and div

DocID: 17xeS - View Document